Vaccines exist to prevent Ebola, but there is no approved vaccine or drug treatment for the Sudan strain of the virus, which caused the recent outbreak in Uganda. A clinical trial of three vaccines — made by the Washington-based Sabin Vaccine Institute, the University of Oxford and the American pharmaceutical company Merck — is being prepared. Researchers have also begun a clinical trial of two monoclonal antibodies donated by the United States that can help boost patients’ chances of survival.
‘Ebola Could Have Wiped Us All’: Slow Lockdown Haunts Uganda
‘Ebola-Could-Have-Wiped-Us-All-12-8-22.png
Learn More
Discover the cutting-edge science we fund
Providing many of the world's best researchers, scientists, and universities with support, and funding to discover breakthroughs that solve humankind's greatest challenges.
See how we support great cultural institutions around the world
The Foundation contributes to renowned institutions that showcase the breadth of arts and culture, including performance, exhibition and education.
Visit the Blavatnik Archive
The Blavatnik Archive is a nonprofit foundation dedicated to preserving and disseminating materials that contribute to the study of 20th-century Jewish and world history, with a special emphasis on World War I, World War II, and Soviet Russia.
